Literature DB >> 29028570

Bovine ovarian follicular growth and development correlate with lysophosphatidic acid expression.

Emilia Sinderewicz1, Katarzyna Grycmacher2, Dorota Boruszewska3, Ilona Kowalczyk-Zięba4, Joanna Staszkiewicz5, Tomasz Ślężak6, Izabela Woclawek-Potocka7.   

Abstract

The basis of successful reproduction is proper ovarian follicular growth and development. In addition to prostaglandins and vascular endothelial growth factor, a number of novel factors are suggested as important regulators of follicular growth and development: PGES, TFG, CD36, RABGAP1, DBI and BTC. This study focuses on examining the expression of these factors in granulosa and thecal cells that originate from different ovarian follicle types and their link with the expression of lysophosphatidic acid (LPA), known local regulator of reproductive functions in the cow. Ovarian follicles were divided into healthy, transitional, and atretic categories. The mRNA expression levels for PGES, TFG, CD36, RABGAP1, DBI and BTC in granulosa and thecal cells in different follicle types were measured by real-time PCR. The correlations among expression of enzymes synthesizing LPA (autotaxin, phospholipase A2), receptors for LPA and examined factors were measured. Immunolocalization of PGES, TFG, CD36, RABGAP1, DBI and BTC was examined by immunohistochemistry. We investigated follicle-type dependent mRNA expression of factors potentially involved in ovarian follicular growth and development, both in granulosa and thecal cells of bovine ovarian follicles. Strong correlations among receptors for LPA, enzymes synthesizing LPA, and the examined factors in healthy and transitional follicles were observed, with its strongest interconnection with TFG, DBI and RABGAP1 in granulosa cells, and TFG in thecal cells; whereas no correlations in atretic follicles were detected. A greater number of correlations were found in thecal cells than in granulosa cells as well as in healthy follicles than in transitional follicles. These data indicate the role of LPA in the growth, development and physiology of the bovine ovarian follicle.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cow; Granulosa; Lysophosphatidic acid; Ovarian follicle; Ovulation; Theca

Mesh:

Substances:

Year:  2017        PMID: 29028570     DOI: 10.1016/j.theriogenology.2017.09.027

Source DB:  PubMed          Journal:  Theriogenology        ISSN: 0093-691X            Impact factor:   2.740


  5 in total

1.  Lysophosphatidic acid supports the development of vitrified ovarian follicles by decreasing the incidence of cell death: An experimental study.

Authors:  Neda Abedpour; Nassim Ghorbanmehr; Mojdeh Salehnia
Journal:  Int J Reprod Biomed       Date:  2022-05-23

2.  Lysophosphatidic acid as a regulator of endometrial connective tissue growth factor and prostaglandin secretion during estrous cycle and endometrosis in the mare.

Authors:  Anna Szóstek-Mioduchowska; Natalia Leciejewska; Beata Zelmańska; Joanna Staszkiewicz-Chodor; Graça Ferreira-Dias; Dariusz Skarzynski
Journal:  BMC Vet Res       Date:  2020-09-17       Impact factor: 2.741

Review 3.  Coming of Age for Autotaxin and Lysophosphatidate Signaling: Clinical Applications for Preventing, Detecting and Targeting Tumor-Promoting Inflammation.

Authors:  Matthew G K Benesch; Iain T K MacIntyre; Todd P W McMullen; David N Brindley
Journal:  Cancers (Basel)       Date:  2018-03-15       Impact factor: 6.639

4.  Metabolomic profiling of ovary in mice treated with FSH using ultra performance liquid chromatography/mass spectrometry.

Authors:  Liting Sun; Lu Chen; Yanwen Jiang; Yun Zhao; Fengge Wang; Xue Zheng; Chunjin Li; Xu Zhou
Journal:  Biosci Rep       Date:  2018-11-20       Impact factor: 3.840

5.  Supplementation of Culture Media with Lysophosphatidic Acid Improves The Follicular Development of Human Ovarian Tissue after Xenotransplantaion into The Back Muscle of γ-Irradiated Mice.

Authors:  Zeynab Mohammadi; Nasim Hayati Roodbari; Kazem Parivar; Mojdeh Salehnia
Journal:  Cell J       Date:  2019-12-15       Impact factor: 2.479

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.